<DOC>
	<DOCNO>NCT02534896</DOCNO>
	<brief_summary>This study designate evaluate safety efficacy Sunpharma1505 subject active rheumatoid arthritis experience flare/exacerbation .</brief_summary>
	<brief_title>To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>1 . Subjects able willing give write informed consent available entire study . 2 . Male female â‰¥ 18 year old 3 . Willing able comply study protocol visit , assessment accessible follow 4 . Known Diagnosed Rheumatoid arthritis 5 . Subjects child bear potential nonlactating must practice acceptable method birth control judge Investigator 1 . Subjects pregnant intend become pregnant study 2 . Subject positive hepatitis panel / antihepatitis B core antibody , / hepatitis C virus antibody [ antiHCV ] ) , / positive Human immunodeficiency virus ( HIV ) antibody . 3 . Known sensitivity component study drug previous hypersensitivity reaction clinically significant reaction IV medication , biologic therapy IV radiocontrast agent . 4 . Active infection require systemic treatment 5 . Planned surgery study period undergone major surgery within 60 Days prior Screening visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>